MD. Abu Bashar

MD. Abu Bashar

Institute of Medical Sciences BHU, Varanasi, Uttar Pradesh, India

Profile ID RP-000-2844 Joined 2023-01-19 2 articles
1
Total Views
2
Total Publications
5
Publication Views

Articles(2)

Are children and adolescents more susceptible to the new strains of SARS-CoV-2 than the earlier ones? 2021

Authors: MD. Abu Bashar, Imran Ahmed Khan

DOI: 10.18231/j.jpmhh.2021.003  

Volume7

Issue1

Pages10-11

Abstract

The clinical impact of the new SARS-CoV-2 lineage B.1·1.7 on children and young people (aged 18 years or younger) regarding acute respiratory COVID-19 is yet to be fully defined. Media reports of increases in admissions to hospital and more serious illness in children and young people have resulted in public confusion and implicated the B.1.1.7 variant as a more pathogenic infection within this group. Keywords: Children, Adolescents, SARS-CoV-2, B.1.1.7, strains

View Article
Chloroquine and Hydroxychloroquine: Are they really wonder drugs for COVID 19? 2020

Authors: MD Abu Bashar, Nazia Begam

DOI: 10.18231/j.jchm.2020.013  

Volume7

Issue2

Pages64-66

Abstract

Despite limited and conflicting data on the use of Chloroquine and hydroxychloroquine in patients with Covid-19, the U.S. Food and Drug Administration(FDA) has authorized the emergency use of these drug on March 28, 2020 given the clinical trials are unavailable or infeasible. Hydroxychloroquine, alone or in combination with azithromycin, is being widely used in Covid-19 therapy based on anecdotal and limited observational evidence. Keywords: Hydroxychloroquine.

View Article

No matching articles

Try another word from the title, author or DOI.